A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 162 participants.

Also called NCT01052779

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 162 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01052779
  • EudraCT 2009-015630-30
Other papers using this trial's data
  • A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD Clinical journal of the American Society of Nephrology : CJASN, 2014-04 DOI, PubMed 24458078, PMC3974353 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Belgium, Canada, Germany, India, Poland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01052779. Randomized; no masking; primary purpose treatment. Start 2010-03-01 (actual); primary completion 2011-07-19 (actual). Results posted on 2018-05-15.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease
Acronym
FIRST
Condition
Iron Deficiency
Condition
Anemia
Condition
Kidney Disease
Intervention (Drug)
Ferumoxytol
Intervention (Drug)
Iron Sucrose
Lead sponsor
AMAG Pharmaceuticals, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01052779
Content hash
f7b0bd0d71650b1b13e600388fae45ea8e9d8d7feffc4176419773fabf2337bd